Introduction Adeno-associated virus (AAV)-mediated gene therapy holds significant promise for treating monogenic disorders of the central nervous system (CNS) caused by loss-of-function (LOF) mutations in protein-coding genes.
Thanks alot for sharing invaluable article
Thanks alot for sharing invaluable article